Fresenius Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Fresenius Medical Care
FMS Stock  USD 25.80  0.35  1.34%   
Fresenius Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Fresenius Medical's valuation are provided below:
Gross Profit
4.8 B
Profit Margin
0.0317
Market Capitalization
15.4 B
Enterprise Value Revenue
1.1577
Revenue
19.5 B
There are over one hundred nineteen available fundamental signals for Fresenius Medical Care, which can be analyzed over time and compared to other ratios. All traders should verify Fresenius Medical's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 5.1 B in 2025. Enterprise Value is likely to drop to about 10.1 B in 2025

Fresenius Medical Total Revenue

11.73 Billion

Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 268.2 M, Total Revenue of 11.7 B or Gross Profit of 3.8 B, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0136 or PTB Ratio of 0.84. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Build AI portfolio with Fresenius Stock
Check out the analysis of Fresenius Medical Correlation against competitors.

Fresenius Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding607.5 M674.9 M578.3 M
Pretty Stable
Total Assets19.3 B33.6 B24.7 B
Slightly volatile
Short and Long Term Debt Total6.5 B11 B8.8 B
Slightly volatile
Other Current Liabilities1.9 B3.1 B2.3 B
Slightly volatile
Total Current Liabilities3.7 B5.7 B4.7 B
Slightly volatile
Total Stockholder Equity8.1 B14.6 B10.3 B
Slightly volatile
Property Plant And Equipment Net7.6 B7.3 B4.2 B
Slightly volatile
Net Debt5.8 B9.8 B7.9 B
Slightly volatile
Retained Earnings11.8 B11.3 B7.8 B
Slightly volatile
Accounts Payable548.5 M984.3 M676.4 M
Slightly volatile
Cash614.8 M1.2 B891.7 M
Slightly volatile
Non Current Assets Total14.3 B25.6 B18.4 B
Slightly volatile
Non Currrent Assets Other188.4 M198.3 M1.3 B
Slightly volatile
Cash And Short Term Investments1.5 B1.4 B1.1 B
Slightly volatile
Net Receivables2.6 B3.9 B3.2 B
Slightly volatile
Common Stock Total Equity304.7 M336.8 M300.3 M
Slightly volatile
Liabilities And Stockholders Equity19.3 B33.6 B24.7 B
Slightly volatile
Non Current Liabilities Total7.4 B12.1 B9.5 B
Slightly volatile
Inventory1.1 B2.1 B1.4 B
Slightly volatile
Other Current Assets656.4 M487.4 M661.1 M
Slightly volatile
Other Stockholder Equity3.1 B3.3 B3.1 B
Slightly volatile
Total Liabilities11.1 B17.8 B14.2 B
Slightly volatile
Property Plant And Equipment Gross17.9 B18.8 B6.5 B
Slightly volatile
Total Current Assets5 B7.9 B6.3 B
Slightly volatile
Short Term Debt1.1 B1.2 B1.4 B
Slightly volatile
Intangible Assets1.7 B1.4 B1.6 B
Slightly volatile
Common Stock261 M337.4 M279.9 M
Slightly volatile
Other Liabilities3.2 B3.1 B2 B
Slightly volatile
Other Assets502.4 M427.8 M646.5 M
Slightly volatile
Long Term Debt5.8 B6.3 B6.4 B
Pretty Stable
Property Plant Equipment4 B7.3 B4.9 B
Slightly volatile
Good Will14.4 B15.2 B11.8 B
Slightly volatile
Short Term Investments154.5 M295.6 M125.7 M
Slightly volatile
Long Term Investments911.9 M1.4 B803.3 M
Slightly volatile
Short and Long Term Debt548.5 M577.4 M3.1 B
Slightly volatile
Long Term Debt Total9.7 B9.8 B8.4 B
Slightly volatile
Capital Surpluse2.8 B3.3 B3.7 B
Slightly volatile
Net Invested Capital20.7 B21.4 B18.3 B
Slightly volatile
Cash And Equivalents383.2 M342.9 M420.1 M
Very volatile
Net Working Capital1.5 B2.3 B1.3 B
Slightly volatile
Capital Stock237.5 M264.1 M296.9 M
Slightly volatile

Fresenius Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue11.7 B19.3 B14.8 B
Slightly volatile
Gross Profit3.8 B4.8 B4.6 B
Slightly volatile
EBITDA2.3 B3.2 B2.8 B
Pretty Stable
Net Income708.2 M537.9 M912.9 M
Very volatile
Depreciation And Amortization1.8 B1.7 B1 B
Slightly volatile
Selling General Administrative2.2 B2.4 B2.5 B
Slightly volatile
Other Operating Expenses10.6 B17.9 B13.1 B
Slightly volatile
Research Development110.6 M183.5 M142.1 M
Slightly volatile
Cost Of Revenue8.3 B14.6 B10.3 B
Slightly volatile
Total Operating Expenses2.3 B3.4 B2.8 B
Slightly volatile
Income Before Tax1.2 B1.1 B1.5 B
Very volatile
Net Income Applicable To Common Shares902.8 M537.9 M995.7 M
Pretty Stable
Net Income From Continuing Ops1.1 B740.9 M1.3 B
Slightly volatile
Tax Provision347.3 M316.1 M469.6 M
Slightly volatile
Interest Income68 M71.6 M282.5 M
Slightly volatile
Reconciled Depreciation1.6 B1.7 B1.2 B
Slightly volatile
Selling And Marketing Expenses633.8 M776.5 M795.1 M
Slightly volatile

Fresenius Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.5 B1.4 B909.2 M
Slightly volatile
Depreciation1.8 B1.7 B1.1 B
Slightly volatile
Dividends Paid227.6 M349.2 M278.9 M
Slightly volatile
Capital Expenditures1 B699.4 M1.4 B
Very volatile
Total Cash From Operating Activities1.6 B2.4 B2 B
Slightly volatile
Net Income856.3 M740.9 M1.1 B
Pretty Stable
End Period Cash Flow617.2 M1.2 B895.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.630.66471.1591
Slightly volatile
Dividend Yield0.01360.02720.018
Slightly volatile
PTB Ratio0.840.88181.7324
Slightly volatile
Days Sales Outstanding86.8774.013479.5663
Slightly volatile
Book Value Per Share56.3353.64537.0841
Slightly volatile
Operating Cash Flow Per Share8.528.11776.8994
Slightly volatile
Average Payables618.4 M588.9 M582.4 M
Slightly volatile
Capex To Depreciation0.380.40141.6659
Slightly volatile
PB Ratio0.840.88181.7324
Slightly volatile
EV To Sales0.840.84061.1025
Slightly volatile
Inventory Turnover9.287.05027.8544
Slightly volatile
Net Income Per Share1.741.832.9919
Very volatile
Days Of Inventory On Hand35.5351.771647.3663
Slightly volatile
Payables Turnover12.0114.811514.8515
Slightly volatile
Sales General And Administrative To Revenue0.130.12240.1232
Slightly volatile
Average Inventory1.2 B1.2 B1.1 B
Slightly volatile
Research And Ddevelopement To Revenue0.0070.00950.0093
Slightly volatile
Capex To Revenue0.06120.03620.0944
Slightly volatile
Cash Per Share5.174.92133.5522
Slightly volatile
POCF Ratio5.125.38669.3555
Slightly volatile
Payout Ratio0.450.64910.4911
Pretty Stable
Capex To Operating Cash Flow0.280.29310.7514
Slightly volatile
Days Payables Outstanding28.1324.643124.7848
Slightly volatile
Income Quality2.573.22072.7301
Pretty Stable
ROE0.07110.03690.0891
Slightly volatile
EV To Operating Cash Flow9.876.81218.9558
Slightly volatile
PE Ratio31.7223.894521.7013
Pretty Stable
Return On Tangible Assets0.030.03160.0747
Slightly volatile
Earnings Yield0.03880.04190.0532
Pretty Stable
Intangibles To Total Assets0.580.49280.5165
Slightly volatile
Net Debt To EBITDA1.93.06532.9167
Slightly volatile
Current Ratio1.121.39981.4075
Slightly volatile
Receivables Turnover3.744.93154.6289
Slightly volatile
Graham Number28.9545.18746.4911
Slightly volatile
Shareholders Equity Per Share52.0749.589936.1592
Slightly volatile
Debt To Equity0.580.75320.8249
Very volatile
Capex Per Share1.251.18962.2764
Very volatile
Average Receivables3.8 B3.6 B3.4 B
Slightly volatile
Revenue Per Share69.0765.781451.3557
Slightly volatile
Interest Debt Per Share40.6738.735431.681
Slightly volatile
Debt To Assets0.240.32710.3407
Very volatile
Enterprise Value Over EBITDA4.525.06976.0651
Very volatile
Short Term Coverage Ratios4.344.13272.4281
Pretty Stable
Price Earnings Ratio31.7223.894521.7013
Pretty Stable
Operating Cycle98.7126125
Slightly volatile
Price Book Value Ratio0.840.88181.7324
Slightly volatile
Days Of Payables Outstanding28.1324.643124.7848
Slightly volatile
Dividend Payout Ratio0.450.64910.4911
Pretty Stable
Price To Operating Cash Flows Ratio5.125.38669.3555
Slightly volatile
Pretax Profit Margin0.07890.05470.1023
Slightly volatile
Effective Tax Rate0.370.2990.3208
Slightly volatile
Company Equity Multiplier2.652.30282.4258
Very volatile
Long Term Debt To Capitalization0.260.30050.3623
Slightly volatile
Total Debt To Capitalization0.330.42960.4457
Pretty Stable
Debt Equity Ratio0.580.75320.8249
Very volatile
Quick Ratio1.231.03441.135
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.152.27571.3139
Slightly volatile
Net Income Per E B T0.460.50890.552
Pretty Stable
Cash Ratio0.10.20330.1745
Slightly volatile
Cash Conversion Cycle78.25101101
Slightly volatile
Operating Cash Flow Sales Ratio0.0960.12340.1294
Pretty Stable
Days Of Inventory Outstanding35.5351.771647.3663
Slightly volatile
Days Of Sales Outstanding86.8774.013479.5663
Slightly volatile
Cash Flow Coverage Ratios0.330.21730.2362
Pretty Stable
Price To Book Ratio0.840.88181.7324
Slightly volatile
Fixed Asset Turnover5.172.66394.3264
Slightly volatile
Capital Expenditure Coverage Ratio3.583.41191.8369
Slightly volatile
Price Cash Flow Ratio5.125.38669.3555
Slightly volatile
Enterprise Value Multiple7.147.07419.2135
Slightly volatile
Debt Ratio0.240.32710.3407
Very volatile
Cash Flow To Debt Ratio0.330.21730.2362
Pretty Stable
Price Sales Ratio0.630.66471.1591
Slightly volatile
Return On Assets0.03030.0160.0373
Slightly volatile
Asset Turnover0.730.5760.6165
Pretty Stable
Net Profit Margin0.04470.02780.0615
Slightly volatile
Gross Profit Margin0.360.2460.3192
Slightly volatile
Price Fair Value0.840.88181.7324
Slightly volatile
Return On Equity0.07110.03690.0891
Slightly volatile

Fresenius Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.1 B6.4 B8.3 B
Pretty Stable
Enterprise Value10.1 B14.6 B16.5 B
Slightly volatile

Fresenius Fundamental Market Drivers

Forward Price Earnings11.2486
Cash And Short Term Investments1.4 B

Fresenius Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue82.2 M78.1 M
Total Revenue19.3 B11.7 B
Cost Of Revenue14.6 B8.3 B
Sales General And Administrative To Revenue 0.12  0.13 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.04  0.06 
Revenue Per Share 65.78  69.07 
Ebit Per Revenue 0.07  0.13 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY